The Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal Tumors

New scientific insights in cancer biology and immunobiology have changed the clinical practice of medical oncology in recent years. The molecular stratification of solid tumors has led to improved clinical outcomes and is a key part in the diagnostic workup. Beyond mutational spectra (like Rat sarco...

Full description

Saved in:
Bibliographic Details
Main Authors: Halama, Niels (Author) , Haberkorn, Uwe (Author)
Format: Article (Journal)
Language:English
Published: 8 July 2020
In: Seminars in nuclear medicine
Year: 2020, Volume: 50, Issue: 5, Pages: 389-398
ISSN:1558-4623
DOI:10.1053/j.semnuclmed.2020.06.003
Online Access:Verlag, Volltext: https://doi.org/10.1053/j.semnuclmed.2020.06.003
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0001299820300696
Get full text
Author Notes:Niels Halama, and Uwe Haberkorn

MARC

LEADER 00000caa a2200000 c 4500
001 173387657X
003 DE-627
005 20230426163456.0
007 cr uuu---uuuuu
008 200928s2020 xx |||||o 00| ||eng c
024 7 |a 10.1053/j.semnuclmed.2020.06.003  |2 doi 
035 |a (DE-627)173387657X 
035 |a (DE-599)KXP173387657X 
035 |a (OCoLC)1341361796 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Halama, Niels  |d 1977-  |e VerfasserIn  |0 (DE-588)13087325X  |0 (DE-627)507228723  |0 (DE-576)251045706  |4 aut 
245 1 4 |a The Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal Tumors  |c Niels Halama, and Uwe Haberkorn 
264 1 |c 8 July 2020 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.09.2020 
520 |a New scientific insights in cancer biology and immunobiology have changed the clinical practice of medical oncology in recent years. The molecular stratification of solid tumors has led to improved clinical outcomes and is a key part in the diagnostic workup. Beyond mutational spectra (like Rat sarcoma [RAS] mutations or tumor mutational burden), the investigation of the immunological microenvironment has attracted more efforts. Especially as immunotherapies have changed the standard treatment for some solid tumors dramatically and have become an important part of routine oncology, also for gastrointestinal tumors. Still only a subgroup of patients benefits from immunotherapy in gastrointestinal tumors with prominent examples from colorectal, pancreatic or gastric cancer. Not only microsatellite instability as a marker for response to immunotherapy has shown its utility, there plenty of other approaches currently being investigated to better stratify and understand the microenvironment. But these insights have not translated into clinical utility. Reasons for this are limited technical capabilities for stratification and for coping with heterogeneity of tumor cells and the microenvironment as such. So the situation for gastrointestinal tumors has shown mainly progress for a subgroup of immunotherapy-receptive tumors (eg, microsatellite instability), but advances for the remaining majority have been in the area of stratification and combinatorial therapies, including approaches without chemotherapy. Molecular stratification (eg, B-Rapidly Accelerated Fibrosarcoma [BRAF] V600E mutation in colorectal cancer or NRG1 fusions in Kirsten-rat sarcoma (KRAS) Wild-Type Pancreatic Cancer) has clearly improved the possibilities for directed therapies, but there is a plethora of clinical situations where further developments are needed to improve patient care. Finding these areas and identifying the technical approach to unravel the complexities is the next decisive step. Here the recent advances are summarized and an outlook on possible diagnostic and treatment options in areas of unmet need is given with the context of new molecular imaging possibilities and cutting edge advances in nuclear medicine. 
700 1 |a Haberkorn, Uwe  |d 1959-  |e VerfasserIn  |0 (DE-588)1022913905  |0 (DE-627)717331245  |0 (DE-576)366166352  |4 aut 
773 0 8 |i Enthalten in  |t Seminars in nuclear medicine  |d New York, NY [u.a.] : Elsevier, 1971  |g 50(2020), 5, Seite 389-398  |h Online-Ressource  |w (DE-627)378128027  |w (DE-600)2133379-8  |w (DE-576)121466868  |x 1558-4623  |7 nnas  |a The Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal Tumors 
773 1 8 |g volume:50  |g year:2020  |g number:5  |g pages:389-398  |g extent:10  |a The Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal Tumors 
856 4 0 |u https://doi.org/10.1053/j.semnuclmed.2020.06.003  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0001299820300696  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20200928 
993 |a Article 
994 |a 2020 
998 |g 1022913905  |a Haberkorn, Uwe  |m 1022913905:Haberkorn, Uwe  |d 910000  |d 911400  |e 910000PH1022913905  |e 911400PH1022913905  |k 0/910000/  |k 1/910000/911400/  |p 2  |y j 
998 |g 13087325X  |a Halama, Niels  |m 13087325X:Halama, Niels  |d 910000  |d 910100  |d 50000  |e 910000PH13087325X  |e 910100PH13087325X  |e 50000PH13087325X  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN173387657X  |e 3763734449 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"10 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["173387657X"],"doi":["10.1053/j.semnuclmed.2020.06.003"]},"relHost":[{"pubHistory":["1.1971 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"The Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal TumorsSeminars in nuclear medicine","recId":"378128027","language":["eng"],"id":{"issn":["1558-4623"],"zdb":["2133379-8"],"eki":["378128027"]},"part":{"issue":"5","extent":"10","volume":"50","text":"50(2020), 5, Seite 389-398","pages":"389-398","year":"2020"},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 16.03.20"],"origin":[{"publisherPlace":"New York, NY [u.a.] ; Duluth, Minn.","dateIssuedKey":"1971","dateIssuedDisp":"1971-","publisher":"Elsevier ; Saunders"}],"title":[{"title_sort":"Seminars in nuclear medicine","title":"Seminars in nuclear medicine"}]}],"note":["Gesehen am 28.09.2020"],"person":[{"given":"Niels","display":"Halama, Niels","family":"Halama","role":"aut"},{"role":"aut","family":"Haberkorn","given":"Uwe","display":"Haberkorn, Uwe"}],"recId":"173387657X","name":{"displayForm":["Niels Halama, and Uwe Haberkorn"]},"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"8 July 2020"}],"language":["eng"],"title":[{"title_sort":"Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal Tumors","title":"The Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal Tumors"}]} 
SRT |a HALAMANIELUNMETNEEDS8202